Pesquisas alternativas:
disease levels » disease level (Expandir a Pesquisa), dismutase levels (Expandir a Pesquisa), decrease levels (Expandir a Pesquisa)
drug disease » drug release (Expandir a Pesquisa)
levels other » levels another (Expandir a Pesquisa), levels rather (Expandir a Pesquisa), levels over (Expandir a Pesquisa)
doses devel » dose level (Expandir a Pesquisa), doses seven (Expandir a Pesquisa), doses derived (Expandir a Pesquisa)
dose levels » noise levels (Expandir a Pesquisa)
devel ther » novel ther (Expandir a Pesquisa), level theory (Expandir a Pesquisa), develop them (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)
disease levels » disease level (Expandir a Pesquisa), dismutase levels (Expandir a Pesquisa), decrease levels (Expandir a Pesquisa)
drug disease » drug release (Expandir a Pesquisa)
levels other » levels another (Expandir a Pesquisa), levels rather (Expandir a Pesquisa), levels over (Expandir a Pesquisa)
doses devel » dose level (Expandir a Pesquisa), doses seven (Expandir a Pesquisa), doses derived (Expandir a Pesquisa)
dose levels » noise levels (Expandir a Pesquisa)
devel ther » novel ther (Expandir a Pesquisa), level theory (Expandir a Pesquisa), develop them (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)
1
“...High levels of plasma triglycerides (TG) are a risk factor for cardiovascular diseases, often...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Prothon, Susanne, Wählby Hamrén, Ulrika, Tehler, Ulrika, Yoon, Esther, Forsman, Henrik, Arfvidsson, Cecilia, Aggarwal, Ajay, Chen, Yingxue
Publicado no Drug Des Devel Ther (2019)
“... dose level following multiple doses. There were no or only marginal effects on other biomarkers tested...”Publicado no Drug Des Devel Ther (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Cogollo, Estafania, Silva, Marta Amaral, Isenberg, David
Publicado no Drug Des Devel Ther (2015)
“... disease who have failed conventional drugs. In contrast, clinical trials using atacicept which blocks both...”Publicado no Drug Des Devel Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Wang, Yuren, Wallach, Jason, Duane, Stephanie, Wang, Yuan, Wu, Jianghong, Wang, Jeffrey, Adejare, Adeboye, Ma, Haiching
Publicado no Drug Des Devel Ther (2017)
“... investigated as important therapeutic targets for cancer and other diseases. Different subtypes of HDACs appear...”Publicado no Drug Des Devel Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Tan, Qian, Hu, Jing, Zhou, Yujing, Wan, Yunxiao, Zhang, Chuanlan, Liu, Xin, Long, Xingyao, Tan, Fang, Zhao, Xin
Publicado no Drug Des Devel Ther (2021)
“... changes in the colon, and LLSL-HFY14 effectively alleviated the disease. LLSL-HFY14 increased serum levels...”Publicado no Drug Des Devel Ther (2021)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Kono, Yasushi, Fukuda, Shota, Shimada, Kenei, Nakanishi, Koki, Otsuka, Kenichiro, Kubo, Tomoichiro, Jissho, Satoshi, Taguchi, Haruyuki, Yoshikawa, Junichi, Yoshiyama, Minoru
Publicado em 2013
“...BACKGROUND: It has been reported that pitavastatin improves endothelial function faster than other...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
“... arthritis (SJIA) differ from other types of juvenile idiopathic arthritis and are similar to other...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
“... kidney disease, cancer (including leukemia and solid tumors), and other diseases. In this review, we...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Zhang, Mingyan, Yan, Zhibin, Bu, Lili, An, Chunmei, Wang, Dan, Liu, Xin, Zhang, Jianfeng, Yang, Wenle, Deng, Bochuan, Xie, Junqiu, Zhang, Bangzhi
Publicado no Drug Des Devel Ther (2018)
“... is the major cause of end-stage renal disease. Current therapeutic strategies slow down but cannot reverse...”Publicado no Drug Des Devel Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
“...In the therapeutic scenario of disease-modifying therapies for relapsing–remitting multiple...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo